Pyroglutamylated amyloid-β correlates with hyperphosphorylated tau and severity of Alzheimer's disease

被引:0
|
作者
Walker, L. [1 ]
Mandler, M. [2 ]
Santic, R. [2 ]
Hanson, P. [3 ]
Upadhaya, A. R. [4 ]
Colloby, S. J. [2 ]
Morris, C. M. [3 ]
Thal, D. R. [4 ]
Thomas, A. J. [2 ]
Schneeberger, A. [1 ]
Attems, J. [2 ]
机构
[1] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[2] AFFiRiS AG, Vienna Bioctr, Vienna, Austria
[3] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[4] Univ Ulm, Clin Res Ctr, Inst Pathol, Neuropathol Lab, D-89069 Ulm, Germany
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P01-12
引用
收藏
页码:42 / 42
页数:1
相关论文
共 50 条
  • [1] Pyroglutamylated Amyloid-β correlates with Hyperphosphorylated Tau and Severity of Alzheimer's Disease
    Attems, Johannes
    Walker, Lauren
    Santic, Radmila
    Upadhaya, Ajeet Rijal
    Colloby, Sean
    Thal, Dietmar
    Thomas, Alan
    Schneeberger, Achim
    Mandler, Markus
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2014, 73 (06): : 587 - 587
  • [2] Pyroglutamylated amyloid-β is associated with hyperphosphorylated tau and severity of Alzheimer's disease
    Mandler, Markus
    Walker, Lauren
    Santic, Radmila
    Hanson, Peter
    Upadhaya, Ajeet Rijal
    Colloby, Sean J.
    Morris, Christopher M.
    Thal, Dietmar R.
    Thomas, Alan J.
    Schneeberger, Achim
    Attems, Johannes
    [J]. ACTA NEUROPATHOLOGICA, 2014, 128 (01) : 67 - 79
  • [3] Pyroglutamylated amyloid-β is associated with hyperphosphorylated tau and severity of Alzheimer’s disease
    Markus Mandler
    Lauren Walker
    Radmila Santic
    Peter Hanson
    Ajeet Rijal Upadhaya
    Sean J. Colloby
    Christopher M. Morris
    Dietmar R. Thal
    Alan J. Thomas
    Achim Schneeberger
    Johannes Attems
    [J]. Acta Neuropathologica, 2014, 128 : 67 - 79
  • [4] Pathogenesis of Alzheimer's Disease: Role of Amyloid-β and Hyperphosphorylated Tau Protein
    Sajjad, Rabia
    Arif, Rawaba
    Shah, A. A.
    Manzoor, I.
    Mustafa, G.
    [J]. INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 80 (04) : 581 - 591
  • [5] Pyroglutamylated amyloid-β is associated with hyperphosphorylated tau in human post mortem brains
    Attems, J.
    Walker, L.
    Santic, R.
    Colloby, S. J.
    Upadhaya, A. Rijal
    Thal, D. R.
    Schneeberger, A.
    Mandler, M.
    [J]. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2014, 40 : 30 - 30
  • [6] Is pyroglutamylated β amyloid associated with tau hyperphosphorylated at tyrosine
    Walker, L.
    Smith, D.
    McAleese, K.
    Johnson, M.
    Attems, J.
    [J]. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2018, 44 : 14 - 14
  • [7] Amyloid-β and Hyperphosphorylated tau Synergy Drives Metabolic Decline in Preclinical Alzheimer's Disease
    Pascoal, Tharick
    Mathotaarachchi, Sulantha
    Benedet, Andrea
    Beaudry, Tom
    Gauther, Serge
    Neto, Pedro Rosa
    [J]. NEUROLOGY, 2016, 86
  • [8] Amyloid-β and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer’s disease
    T A Pascoal
    S Mathotaarachchi
    S Mohades
    A L Benedet
    C-O Chung
    M Shin
    S Wang
    T Beaudry
    M S Kang
    J-P Soucy
    A Labbe
    S Gauthier
    P Rosa-Neto
    [J]. Molecular Psychiatry, 2017, 22 : 306 - 311
  • [9] Accumulated Amyloid-β Peptide and Hyperphosphorylated Tau Protein: Relationship and Links in Alzheimer's Disease
    Huang, Han-Chang
    Jiang, Zhao-Feng
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2009, 16 (01) : 15 - 27
  • [10] Amyloid-β and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer's disease
    Pascoal, T. A.
    Mathotaarachchi, S.
    Mohades, S.
    Benedet, A. L.
    Chung, C-O
    Shin, M.
    Wang, S.
    Beaudry, T.
    Kang, M. S.
    Soucy, J-P
    Labbe, A.
    Gauthier, S.
    Rosa-Neto, P.
    [J]. MOLECULAR PSYCHIATRY, 2017, 22 (02) : 306 - 311